Prostatype Genomics receives funding from EIT Health!

EIT Health is a network of best-in-class health innovators backed by the EU. The organization’s aim is to deliver solutions to enable European citizens to live longer, healthier lives by promoting innovation. Through various programs EIT Health sponsors companies with new products and solutions for the Healthcare sector that will improve prevention, predicition, diagnosis, treatment and follow up. In one of the organization’s initiatives Prostatype Genomics AB was selected to receive funding in order to promote the company’s activities. In tough competition with 29 great applications five companies were selected to receive funding and Prostatype Genomics with the Product Prostatype was one of them.